Cellular potassium ion deprivation enhances apoptosis induced by cisplatin

Basic and Clinical Pharmacology and Toxicology

Volumn 94, Issue 5, 2004, Pages 245-251

  Marklund, Linda ^a   Andersson, Britta ^a   Behnam Motlagh, Parviz ^a   Sandström, Per Erik ^a   Henriksson, Roger ^a   Grankvist, Kjell ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BUMETANIDE; CISPLATIN; POTASSIUM ION; RUBIDIUM 86; SODIUM POTASSIUM CHLORIDE COTRANSPORTER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; MESOTHELIOMA; NUCLEOSOME; POTASSIUM TRANSPORT; PRIORITY JOURNAL;

EID: 2442687779     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto940508.x     Document Type: Article

References (34)

1. Barbiero, G., F. Duranti, G. Bonelli, J. S. Amenta & F. M. Baccino: Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp. Cell Res. 1995, 217, 410-418.
2. Barry, M. A., C. A. Behnke & A. Eastman: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 1990, 40, 2353-2362.
3. Beketic-Oreskovic, L. & M. Osmak: Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Cancer Chemother. Pharmacol. 1995, 35, 327-333.
4. Beauvais, F., L. Michel & L. Dubertret: Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis. Role of K+ channels. J. Leukoc. Biol. 1995, 57, 851-855.
5. Bergström, P., K. Grankvist, S. Holm & R. Henriksson: Effects of antimicrobial drugs on the cytotoxicity of epirubicin, bleomycin, estramustine and cisplatin. Anticancer Res. 1991, 11, 1039-1044.
6. Bergström, P., A. Johnson, E. Cavallin-Stahl, T. Bergenheim & R. Henriksson: Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat. Eur. J. Cancer 1997, 33, 153-159.
7. + efflux in the activation of apoptosis. J. Biol. Chem. 1997, 272, 32436-32442.
8. Dallaporta, B., T. Hirsch, S. A. Susin, N. Zamzami, N. Larochette, C. Brenner, I. Marzo & G. Kroemer: Potassium leakage during the apoptotic degradation phase. J. Immunol. 1998, 160, 5605-5615.
9. Eastman, A.: Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990, 2, 275-280.
10. Ferguson, P.-J., C. Currie & M. D. Vincent: Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II. Drug Metab. Dispos. 1999, 27, 1399-1405.
11. + cotransporter in the rectal gland of Squalus acanthias is activated by cell shrinkage. Eur. J. Physiol. 1999, 438, 165-176.
12. Hoffman, E. K. & P. B. Dunham: Membrane mechanisms and intracellular signalling in cell volume regulation. Int. Rev. Cytol. 1995, 161, 173-242.
13. + suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem. 1997, 272, 30567-30576.
14. Hsu, S. F. & R. R. Burnette: The effect of amphotericin B on the K-channel activity of MDK cells. Biochim. Biophys. Acta 1997, 1152, 189-191.
15. Krick, S., O. Platoshyn, M. Sweeney, H. Kim & J. X. Yuan: Activation of K+ channels induces apoptosis in vascular smooth muscle cells. Amer. J. Physiol. Cell Physiol. 2001, 280, C970-C979.
16. Lang, F., G. L. Busch, M. Ritter, H. Volkl, S. Waldegger, E. Gulbins & D. Haussinger: Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 1998, 78, 247-306.
17. Lytle, C.: Activation of the avian erythrocyte Na-K-Cl cotransport protein by cell shrinkage, cAMP, fluoride, and calyculin-A involves phosphorylation at common sites. J. Biol. Chem. 1997, 272, 15069-15077.
18. Maeno, E., Y. Ishizaki, T. Kanaseki, A. Hazama & Y. Okada: Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. USA 2000, 97, 9487-9492.
19. + flux. J. Antimicrob. Chemother. 2001a, 48, 781-786.
20. - cotransport blocker bumetanide. Life Sci. 2000, 66, PL-319-324.
21. Marklund, L., R. Henriksson & K. Grankvist: Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. Int. J. Cancer 2001b, 93, 577-583.
22. Mese, H., A. Sasaki, S. Nakayama, R. E. Alcade & A. T. Matsumura: The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line. Cancer Chemother. Pharmacol. 2000, 46, 241-245.
23. Morikage, T., M. Bungo, M. Inomata, M. Yoshida, T. Ohomori, Y. Fujiwara, K. Nishio & N. Saijo: Reversal of cisplatin resistance with amphotericin B in a non-small cell lung cancer cell line. Jap. J. Cancer Res. 1991, 82, 747-751.
24. Morikage, T., T. Ohmori, K. Nishio, Y. Fujiwara, Y. Takeda & N. Saijo: Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res. 1993, 53, 3302-3307.
25. Poulain, L., F. Sichel, H. Crouet, F. Bureau, P. Gauduchon, M. Gignoux & J. Y. Le-Talaer: Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells. Cancer Chemother. Pharmacol. 1997, 40, 385-390.
26. + conductance in the isolated bullfrog cornea. Biochim. Biophys. Acta 1990, 1026, 13-20.
27. Sabra, R. & R. A. Branch: Amphotericin B nephrotoxicity. Drug Saf. 1990, 5, 94-108.
28. Sandström, P.-E., O. Jonsson, K. Grankvist & R. Henriksson: Identification of potassium ion flux pathways and their role in the cytotoxicity o estramustine in human glioma, prostatic and pulmonary carcinoma cell lines. Eur. J. Cancer 1994, 12, 1822-1826.
29. Seki, K., H. Yoshikawa, K. Shiiki, Y. Hamada, N. Akamatsu & K. Tasaka: Cisplatin (CDDP) specially induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarkoma. Cancer Chemother. Pharmacol. 2000, 45, 199-206.
30. Sharp, S. Y., P. Mistry, M. R. Valenti, A. P. Bryant, L. R. & L. R. Kelland: Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian cell lines by amphotericin B. Cancer Chemother. Pharmacol. 1994, 35, 137-143.
31. Thompson, G. J., C. Langlais, K. Cain, E. C. Conley & G. M. Cohen: Elevated extracellular [K+] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem. J. 2001, 357, 137-145.
32. Wang, X., A. Y. Xiao, T. Ichinose & S. P. Yu: Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J. Exp. Pharmacol. 2000, 295, 524-530.
33. Yu, S. P., C. H. Yeh, S. L. Sensi, B. J. Gwag, L. M. Canzoniero, Z. S. Farhangrazi, H. S. Ying, M. Tian, L. L. Dugan & D. W. Choi: Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997, 278, 114-117.
34. Yu, S. P., C. Yeh, U. Strasser, M. Tian & D. W. Choi: NMDA receptor-mediated K+ efflux and neuronal apoptosis. Science 1999, 284, 336-339.